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Poster Session I S287analysis of TMC and RIC cohorts from time of first HPCT showed
that all SMNs occurred in TMC patients who underwent HPCT for
malignancies, and 12/23 (52%) of SMNs were among allogeneic
HPCTs; 7% (12/166) SMNs developing in this total allogeneic co-
hort. Mean follow up for all TMCs in this group is 8.8 years and for
SMNs is 2.6 years from SMN onset (std. error 5 0.37) with overall
mortality of 26%.Mean time of SMN fromHPCTwas 15 years with
a range of 3.8–16 years. SMNs included thyroid papillary carcinoma
(8), MDS/AML (7), osteogenic sarcoma (3), chondrosarcoma (1),
gastrointestinal stromal tumor (GIST) (1), primitive neuroectoder-
mal tumor (PNET) (1), mucinous bile duct adenocarcinoma (1),
and Kaposi’s sarcoma (1). Comparing allogeneic TMC with SMN
to allogeneic RIC treated for malignancies, survival analysis censor-
ing for time at risk in RIC and time to SMN in TMC showed no sig-
nificant difference (log rank p5 .8364) with amean follow up for this
RIC group at 10.95 years and 15.03 years for the SMN in TMCs.
There was a difference between the same RIC group and autologous
HPCT with SMNs (n 5 11) in which 9/11 (82%) had HPCT for
NBL IV; despite no TBI for autologous HPCT these patients are
likely high risk for SMNs due to factors of prior exposure including
high doses of alkylating agents, topoisomerases, epidophyllotoxins,
and focal radiation. Although overall follow up time is relatively
short at a mean of 10 years, comparing time at risk among RIC pa-
tients to time to development of SMNs in TMC patients showed
no significant difference. This may support the hypothesis that de-
creasing or avoiding total body irradiation doses will lead to fewer
SMNs in survivors.224
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Background: Advances in hematopoeitic stem-cell transplantation
(HSCT) have significantly improved long-term survival and
HSCT is now the therapeutic treatment offered to patients with ma-
lignant and nonmalignant hematological diseases. The goal of
HSCT is to cure and enhance patient’s overall quality of life
(QOL); yet, QOL is multidimensional and rarely static. Further, lit-
tle research has compared parental and child perceptions of health
related quality of life. This study examined parental and child per-
ceivedQOLover the first year afterHSCT, exploring physical, emo-
tional, psychosocial, school function, and domains related to therapy
such as worry, nausea, and procedural and treatment anxiety.
Methods: Pediatric HSCT recipients and their parent each com-
pleted a questionnaire package at 3, 6, and 12 months post transplant
which included the Pediatric Quality of Life Inventory 4.0 (PedsQL
4.0) and the PedsQL Cancer Module. Scale scores for physical, psy-
chosocial, school domains were reported out of 100 where higher
scores reflect better functional status. Data were analyzed using de-
scriptive and univariate analyses with SAS software.
Results: There were 19 participants (68% male); 8 adolescents (age
13-18); 10 children ages 8-12; and 1 parent of a child ages 2-7. The
median age at HSCT was 11.5 yrs (range 2-17.2yrs).
Table. PedsQL 4.0 Mean (range) Core Scales for Children and
Parents, and Healthy Reference Scores and PedsQL Cancer
Module: Parent and Child Reports (Median Scores)
Mean
PedsQL 4.0 Parent Report Child Self-Report Reference*Physical Function Scale
3mo (n 5 19) 66 (16-97) 63 (38-97) 88.7
6 mo (n 5 14) 66 (59-100) 89 (47-97)
12 mo (n 5 9) 65 (25-100) 91 (53-100)
School Function Scale
3mo (n 5 19) 75 (35-100) 73 (0-90) 80.4
6 mo (n 5 14) 65 (45-100) 78 (50-100)(Continued )Table. (Continued)PedsQL 4.0 Parent Report Child Self-Report
Mean
Reference*12 mo (n 5 9) 75 (30-100) 80 (45-90)
Psychosocial Summary Score
3mo (n 5 19) 63 (38-93) 60 (0-93) 83.8
6 mo (n 5 14) 80 (25-98) 87 (40-98)
12 mo (n 5 9) 80 (37-100) 88 (38-97)
Cancer Module (median scores at 3m, 6m, 12m)
Pain and Hurt 81, 88, 63 75, 81, 81
Nausea 90, 90, 85 80, 90, 70
Procedural Anxiety 93, 75, 92 75, 75, 85
Treatment Anxiety 75, 83, 98 92, 92, 83
Worry 58.3, 75, 92 92, 85, 67
Physical Appearance 71, 83, 100 83, 88, 83Conclusions: These results suggest that parent and children report
discordant perceptions of QOL ratings after HSCTwith parents re-
porting lower functional status across almost all domains. For the
physical and psychosocial, and school scores are lower than healthy
child reference norms for parental ratings indicating concerns in
these domains. However by the 6 and 12 month mark after
HSCT, children are rating their QOL comparable to healthy peer
scores. Of note, parents experienced markedly less ‘‘worry’’ over
the first year (about treatment, side effects, social and interpersonal
relations, and child’s future), while children reported increasing
‘worry’ over the first year.Wewill further explore the role of etiology
for transplant and age of child and its impact on these findings; stud-
ies are needed to explore discordant parental and child perceptions of
QOL to improve outcomes for pediatric HSCT recipients.225
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Patients with Fanconi Anemia (FA) often have compromised nu-
tritional status, especially low birth weight and short stature. Once
the Hematopoietic Stem Cell Transplantation (HSCT) causes loss
of appetite and increased energy expenditure, nutritional status of
these patients may be further compromised. Knowing that the phase
angle (PA) has been considered a prognostic and nutritional status
indicator in several clinical situations, considering its use as an
body cell mass estimate value, the aim of this study was to evaluate
the PA in patients with FA undergoing HSCT and the association
between PA and nutritional parameters. The nutritional status of
24 patients and 25 controls, aged from 5 to 16 years old, was assessed
by bioelectric impedance analysis (BIA) and anthropometric mea-
surements before patients started conditioning for HSCT and 30
and 180 days after HSCT. The PA was calculated (reactance/resis-
tance) and expressed in degrees. Dietary intake was assessed by 24-
hour recall. Of the 24 patients studied, 11 (45.8%) were male, with
an average age 9.746 3.2 years and mean PA of 5.8 6 0.82. The pa-
tients had lower PA values than the control (5.86 0.16 versus 6.36
0.13, respectively, p 5 0.02). Was observed a decrease of 17.3% in
the value of AF 30 days after transplantation (p5 0.02). On the other
hand, there was no reduction in mean BMI and FFM after transplan-
tation (p.0.05). Lower values of AF were found in patients classified
as malnourished according to weight / age (p5 0.007) as well as pa-
tients with weight loss 180 days after transplantation (p 5 0.002).
The PAwas positively correlated with age (r5 0.660 p\0.001), pro-
tein intake (r5 0.663 p5 0.003), BMI (r5 0.762 p\0.001), Triceps
skinfold thickness (r 5 0.457 p 5 0.02), Arm muscle circunference
(r 5 0.754 p\0,001) and Fat free mass (r 5 0.694 p\0.001). The
present study demonstrated that PA can be used as an indicator of
nutritional status in children with AF undergoing HSCT.
